Pluristem Therapeutics Inc.
Head Quarters
Building No. 5 MATAM Advanced Technology Park USWebsite
http://www.pluristem.comIndustry
BiotechnologyEmployees
169Exchange
NASDAQPluristem Therapeutics, Inc. is a biotechnology company engages in the provision of cell therapy development. It focuses on cell therapies for the treatment of diseases such as muscle injury, acute radiation syndrome, pulmonary arterial hypertension and others. Its products include PLacental eXpanded, PLX-PAD, and PLX-R18. The company was founded by Doron Shorrer on May 11, 2001 and is headquartered in Haifa, Israel.
Key statistics
| Margins | Stock |
|---|---|
| Revenue per Employee | $0.00 |
| Current Ratio | 5 |
| Gross Margin (%) | 0.00% |
| Net Margin (%) | 0.00% |
| Returns | Stock |
| Sales | $0.00 |
| Sales Growth (% qtr vs. yr ago) | 0.00% |
| Net Income | -$5.00M |
| NI Growth (% qtr vs. yr ago) | 0.00% |
| Price/Sales | 0.00 |
| EPS | $0.00 |